Participated · Series A · Nov 2025

IBI Ag is an Israeli agri-biotech company pioneering a platform that uses single-domain antibodies (nanobodies) to create highly selective biological insecticides. Adapted from human therapeutics and optimized for agriculture, its products introduce new modes of action that protect high-value crops from both sucking and chewing pests while sparing beneficial species. The firm positions its technology as a lower-ecological-footprint alternative to conventional chemicals, aiming to help farmers boost yields sustainably. With fresh Series A capital, IBI Ag plans to accelerate product development and advance regulatory filings on multiple bio-insecticide candidates. The company also intends to deepen its collaboration with strategic investor Corteva to speed commercialization. Founded by The Trendlines Group alongside Dr. Amir Ayali and Dr. Rony Oren Benaroya, IBI Ag has been supported by the Israel Innovation Authority since inception. Financial details beyond the recent $10 million raise were not disclosed.

Participated · Seed · Sep 2024

With operates a community calendar and PRM platform that aggregates local events, programs and activities into a single location for residents and municipal leaders. Its AI capabilities can proactively suggest events based on resident demand and interest and provide governments with insights on community demand, preferences and trends. The platform is designed to help governments manage community engagement from planning through measurement, including assessing initiative impacts and ROI. With partners with more than 100 cities and counties across the US, Canada and Israel and has added over 20 North American customers recently, including Scottsdale, Ariz. and Tel Aviv‑Yafo. Led by CEO Adi Perry, the company plans to use the new capital to expand its reach in North America and further develop its AI capabilities to support local leaders. The article does not disclose revenue or unit economics.

Participated · Seed · Jun 2024

illumex provides a Generative Semantic Fabric that automatically discovers, maps and adds semantic meaning to structured enterprise data, creating a unified semantic knowledge graph and domain-specific ontology. The platform reconciles data silos, aligns terminology across sources, and analyzes metadata without accessing underlying sensitive information to preserve governance. By adding consistent business context and vocabulary, illumex aims to enable LLMs to reliably map queries to the correct data points and improve accuracy of GenAI applications. The company says its technology addresses shortcomings of RAG and manual labeling for structured data, reducing ambiguity and duplicate or conflicting records. illumex has enterprise customers including Teva and Carson and partnerships with Microsoft, Google Cloud, and AWS. The company announced a $13M seed funding round to accelerate enabling trustworthy and governed enterprise GenAI with structured data.

Participated · Equity · Apr 2024

Greeneye Technologies, founded in 2017 and led by CEO Nadav Bocher, develops AI-enabled precision spraying technology to offer sustainable alternatives to conventional crop protection. The company harnesses AI and deep machine learning to make intelligent, real-time decisions in the field that are proven to cut chemical use and improve weed-control efficacy versus standard broadcast spraying. Greeneye aims to increase productivity and profitability for farmers while addressing environmental challenges and global food production demand. The firm plans to use the new funding to scale its U.S. operations, advance the technology's analytical capabilities, and extend usage to new inputs and crops. Financially, the company announced a $20M funding raise led by Deep Insight. Greeneye Technology makes an AI-based precision spraying system that retrofits existing machines with cameras and sensors so the system recognizes weeds in real time and sprays only targeted areas. In on-farm field trials the system reduced non-residual herbicide use by an average of 86% while achieving the same weed control and yield as traditional broadcast spraying; a University of Nebraska–Lincoln ARD trial showed an 87% reduction in post-emergence use and a 94% reduction in burndown applications. Greeneye reported trial cost savings of $24.70/acre for pre-emergence and $40.50/acre for post-emergence applications. The company launched the technology in early 2022, said demand exhausted available units for 2023, and treated “tens of thousands of acres” last year. Greeneye plans to scale commercial deployments via partnerships and is targeting a U.S. launch with FBN members for the 2024 growing season, with expansion to Canada and possibly South America under consideration. The product is positioned to lower input costs, improve efficacy, and enable new crop-protection programs by making precise spraying more affordable. Greeneye develops proprietary AI-enabled precision spraying technology that uses deep machine learning to enable intelligent, real-time decisions for precise application of herbicides and other chemicals. The company announced the commercial launch of its technology in October 2021. Greeneye completed a $22M funding round to support commercialization and growth. Proceeds will fund a U.S. commercial launch in 2022 and expansion across North America in 2023, and will be used to advance analytical capabilities and extend use to new inputs and crops. Ahead of these milestones Greeneye will double its R&D team in Israel and its sales and operations team in the U.S. The company was founded in 2017 in Tel Aviv by CEO Nadav Bocher. Greeneye Technology, founded in 2017 and based in Tel Aviv, develops an artificial intelligence platform to detect and spray weeds in real time. Its selective spraying (SSP) system can integrate into any agricultural sprayer by retrofitting existing sprayers or via collaboration with sprayer manufacturers to deliver plant-level variable-rate spraying. The platform maps entire fields with cameras at plant-level resolution and enables targeted, selective applications. The company intends to use the funds to advance product research and development and to expand strategic partnerships with sprayer manufacturers and other stakeholders. Greeneye has attracted participation from both venture and industry investors. Following the round, JVP Partner Michal Drayman and Syngenta Ventures' Managing Director Shubhang Shankar joined Greeneye's board.